Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 119   

Articles published

JNJ 104.30 0.00 (0.00%)
price chart
Johnson & Johnson to Buy Biotech Company Alios BioPharma
Johnson & Johnson said on Tuesday that it would pay $1.75 billion in cash for Alios BioPharma, a private biotechnology company that is working on treatments for viral diseases.
Johnson & Johnson Buying Alios for $1.75B  ABC News
Johnson & Johnson Announces Agreement To Acquire Alios BioPharma  MarketWatch
Related articles »  
Cravath Helps Johnson & Johnson Bag Another Pharma Firm
Drug and pharmaceutical giant Johnson & Johnson has agreed to pay $1.75 billion in cash to acquire Alios BioPharma, a private biotechnology company developing a medicine to combat a serious childhood respiratory infection for which there is no current ...
Johnson & Johnson completes $1.75 billion buyout of Alios BioPharma  Silicon Valley Business Journal
The Daily Startup: Johnson & Johnson Acquires Alios for Record $1.75 Billion  Wall Street Journal (blog)
Related articles »  
Johnson & Johnson to Quicken Development of Ebola Virus Vaccine
"The decision to accelerate the program is based on the fact that it is such a catastrophic situation in West Africa," said Dr.
Johnson & Johnson Pushes Ahead With Ebola Vaccine  NPR (blog)
Johnson & Johnson Responds to Ebola Crisis With Commitment to Accelerate ...  MarketWatch
Related articles »  
Johnson & Johnson Hoping Brand Won't Be Tarnished If They Dip Into Lethal ...
NEW BRUNSWICK, NJ�Saying that the company could cash in big time on the opportunity, Johnson & Johnson CEO Alex Gorsky expressed his hope to reporters Friday that the pharmaceutical manufacturer's family-friendly image would not be tarnished if it ...
One Put, One Call Option To Know About for Johnson & Johnson
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Johnson & Johnson Johnson & Johnson (NYSE: JNJ). So this week we highlight one interesting put contract, and one interesting call ...
Related articles »  
Defective Surgical Product Lawsuits Filed Against Johnson & Johnson
PALM BEACH GARDENS, Fla., Sep 30, 2014 (BUSINESS WIRE) -- Johnson & Johnson has been accused of knowingly developing and marketing a defective medical device known as Prolene� mesh used in hernia surgery in a series of lawsuits filed in New ...
Related articles »  
Johnson & Johnson gas break fixed; 'back to normal,' police chief says
RARITAN BOROUGH - Repairs have been completed on a gas main break that forced the evacuation Wednesday of about 750 from a Johnson & Johnson building on Route 202. At about 10:30 a.m. Wednesday, a contractor was digging to install a new ...
Better Dividend Stock: Johnson & Johnson or Pfizer, Inc?
Beginning with Johnson & Johnson, the company is set up as a three-dimensional healthcare conglomerate. Out of the $71.3 billion the company delivered in revenue last year, $28.1 billion came from global pharmaceutical sales, $28.5 billion from medical ...
Johnson & Johnson Should Ignore Those Breakup Calls
Still, there are plenty of investors calling for Johnson & Johnson to break itself up into smaller pieces, even though the company is posting 9% year-over-year revenue growth.
Johnson & Johnson: The One Stock You Should Ever Own? (JNJ)  Seeking Alpha (registration)
Short Interest in Johnson & Johnson Decreases By 13.2% (JNJ)  Mideast Time
Related articles »  
The New #14 Most Shorted Dow Component: Johnson & Johnson
The most recent short interest data has been released by the NASDAQ for the 09/15/2014 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by ...
Related articles »